|
RIC8A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.842800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.029900E-04 |
| Normal-vs-Stage2 |
2.792600E-01 |
| Normal-vs-Stage3 |
1.619970E-01 |
| Normal-vs-Stage4 |
9.024600E-03 |
| Stage1-vs-Stage2 |
1.895360E-01 |
| Stage1-vs-Stage3 |
3.799600E-02 |
| Stage1-vs-Stage4 |
9.996800E-01 |
| Stage2-vs-Stage3 |
9.804400E-01 |
| Stage2-vs-Stage4 |
2.661200E-01 |
| Stage3-vs-Stage4 |
1.518830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.961700E-03 |
| Normal-vs-AfricanAmerican |
1.494500E-02 |
| Normal-vs-Asian |
7.616100E-02 |
| Caucasian-vs-AfricanAmerican |
4.216600E-01 |
| Caucasian-vs-Asian |
4.612600E-01 |
| AfricanAmerican-vs-Asian |
7.238800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.717500E-02 |
| Normal-vs-Female |
1.583590E-04 |
| Male-vs-Female |
7.799400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.227580E-01 |
| Normal-vs-Age(41-60Yrs) |
5.641800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.152330E-02 |
| Normal-vs-Age(81-100Yrs) |
4.992200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.646400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.220400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.596400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.418800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.243400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.895800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.44080000000913E-05 |
| Normal-vs-Grade 2 |
3.098700E-03 |
| Normal-vs-Grade 3 |
4.024000E-02 |
| Normal-vs-Grade 4 |
2.069800E-02 |
| Grade 1-vs-Grade 2 |
2.304400E-03 |
| Grade 1-vs-Grade 3 |
5.574400E-04 |
| Grade 1-vs-Grade 4 |
8.516700E-03 |
| Grade 2-vs-Grade 3 |
2.429200E-01 |
| Grade 2-vs-Grade 4 |
8.896800E-01 |
| Grade 3-vs-Grade 4 |
4.005000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.81329999999958E-05 |
| Normal-vs-ccB subtype |
3.220400E-01 |
| ccA subtype-vs-ccB subtype |
1.355740E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.016000E-02 |
| Normal-vs-N1 |
1.333230E-01 |
| N0-vs-N1 |
3.106800E-01 |
|
|
